Fundz
A company that just raised surges hiring in 30 to 60 days. Fundz shows you the money, about a month before the job ad.See it live →

LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer

PUBLIC · LBRXSep 15, 2026•1 day ago

Position

Chief Medical Officer

Company

LB Pharmaceuticals

Susan G. Kozauer, M.D.
New YorkHealthcareHealth Care

Description

On September 15, 2026, LB Pharmaceuticals Inc announced the appointment of Susan G. Kozauer, M.D. as the Chief Medical Officer, effective September 14, 2026

Company Information

Company

LB Pharmaceuticals

Location

One Pennsylvania Plaza, Suite 1025

New York, New York, United States

About

LB Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of schizophrenia. Our lead drug candidate is a second-generation antipsychotic and a potential first-in-class benzamide to enter the U.S. market. With robust clinical development underway and a focus on long-term patient outcomes, we aim to set a new standard of care for neuropsychiatric conditions.

Don't miss LB Pharmaceuticals's next move

Get an email the moment LB Pharmaceuticals changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Marc
Likely contact at this company
••••••••@••••••••

See Marc's verified email →

Anna
Likely contact at this company
••••••••@••••••••

See Anna's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for LB Pharmaceuticals's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

LB Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.